Daiwa upgraded Illumina to Buy from Neutral with a price target of $154, up from $120, following the company’s strategy update. The analyst believes Illumina can expand its business results centered on NovaSeqX and finds it possible to balance growth investment and performance improvement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
- Starbucks, Chipotle upgraded: Wall Street’s top analyst calls
- Illumina upgraded to Equal Weight from Underweight at Barclays
- Illumina upgraded to Buy from Hold at TD Cowen
- Illumina poised to accelerate revenue growth into high single digits over 3 yrs